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ABSTRACT
BELL, P. G., M. J. W. FURBER, K. A. VAN SOMEREN, A. ANTO´N-SOLANAS, AND J. SWART. The Physiological Profile of a
Multiple Tour de FranceWinning Cyclist.Med. Sci. Sports Exerc., Vol. 49, No. 1, pp. 115–123, 2017. Introduction: This case study reports
a range of physiological characteristics in a two-time Tour de France champion.Methods: After body composition assessment (dual-energy
x-ray absorptiometry), two submaximal cycling step tests were performed in ambient (20-C, 40%) and hot and humid (30-C, 60% [HH])
conditions from which measures of gross efficiency (GE), lactate-power landmarks, and heart rate responses were calculated. In addition,
thermoregulatory and sweat responses were collected throughout. V˙O2peak and peak power output (PPO) were also identified after a separate
ramp test to exhaustion. Results: V˙O2peak and PPO were 5.91 LImin
j1 (84 mLIkgj1Iminj1) and 525 W, respectively, whereas mean GE values
were 23.0% and 23.6% for ambient and HH conditions, respectively. In addition to superior GE, power output at 4 mmolILj1 lactate was higher
in HH versus ambient conditions (429.6 vs 419.0 W) supporting anecdotal reports from the participant of good performance in the heat. Peak
core and skin temperature, sweat rate, and electrolyte content were higher in HH conditions. Body fat percentage was 9.5%, whereas total fat
mass, lean mass, and bone mineral content were 6.7, 61.5, and 2.8 kg, respectively. Conclusion: The aerobic physiology and PPO values
indentified are among the highest reported for professional road cyclists. Notably, the participant displayed both a high V˙O2peak and GE, which is
uncommon among elite cyclists and may be a contributing factor to their success in elite cycling. In addition, performance in HH conditions
was strong, suggesting effective thermoregulatory physiology. In summary, this is the first study to report physiological characteristics of a
multiple Tour de France champion in close to peak condition and suggests what may be the prerequisite physiological and thermoregulatory
capacities for success at this level. Key Words: CYCLING, PHYSIOLOGY, ENDURANCE, ELITE PERFORMANCE
T
he limits of human endurance performance and the
nature of fatigue have been debated extensively
(1,23,25,31,32,40), and cyclists competing in the
Tour de France (TdF) represent the extremes of endur-
ance performance characteristics. This can be attributed
to unique physiological and morphological characteristics
developed from extensive training-induced adaptations
(21). To date, there is limited information on the physiological
characteristics of TdF cyclists, and even less on the winners
of the race who represent the elite of the elite endurance
athletes. Widely recognized determinants of endurance
cycling performance include gross efficiency (GE), peak
oxygen uptake (V˙O2peak), peak power output (PPO), and
numerous lactate landmarks that represent distinct changes in
aerobic metabolism.
The TdF is a 3-wk stage race that covers variable terrain
in which the winner is the cyclist who completes all the
stages in the lowest overall cumulative time. The key stages
that have been identified as the most relevant to overall
performances are time trial (TT) stages and stages with
uphill finishes (20). During TT stages, cyclists are required
to produce a high absolute power output, usually in excess
of 400 W, for prolonged periods (e1 h) (35). A maximal
40-km TT power has been positively correlated with the
power output produced at a blood lactate concentration of
4 mmolILj1 and has additionally been shown to coincide
with the average power output sustained during the hour
record (2,33). Although this relationship is not universal,
the measurement of sustained maximal power output for a
duration of 1 h (also known as functional threshold power)
is correlated to a blood lactate concentration of 4 mmolILj1
when performing an incremental exercise test in the labo-
ratory. Stages with uphill finishes similarly require very
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high sustained power outputs but, in addition, require a
high power-to-weight ratio. The final climbs of these
types of stages can range from 5 to 20 km in length, re-
quiring maximal power outputs for periods of 10 min
through to 1 h, during which the cyclist will be required to
sustain a continuous power output of more than 6 WIkgj1
(20). A power-to-mass ratio in excess of 6 WIkgj1 coin-
ciding with the blood lactate concentration of 4 mmolILj1
is therefore a requirement for top performances during
uphill finishes at the TdF.
GE is a measure of effective work and is expressed as a per-
centage of total energy expended that produces external work
(12). In well-trained male cyclists, GE was reported as ranging
from 10% to 25% (14), whereas in professional cyclists, GE was
further elevated in the range of 22.0%–28.1% (22). Paradox-
ically, within professional level cyclists, V˙O2peak and cycling
efficiency have been found to be inversely related, and it has
been hypothesized that a high efficiency might compensate
for a relatively low V˙O2peak (22). TdF cyclists typically
demonstrate high GE values with the best cyclists in the TdF
(top 10 overall finishes and stages winners) demonstrating
GE values of ~24% and the winner as high as 25% (39).
A study of a multiple TdF winner measured maximal oxygen
uptake on five separate occasions, four before the athlete_s first
TdF win and one in the year of his first TdF victory (8). These
tests demonstrated large fluctuations in maximal oxygen uptake
ranging from 5.29 to 6.10 LIminj1 between tests. The highest
recorded value of 6.10 LIminj1 (81.2 mLIkgj1Iminj1) was
also recorded 6 yr before the first TdF win. Oxygen uptake at
lactate threshold relative to V˙O2peak was also highly variable
and ranged from 76% to 85%. Interestingly, GE increased
progressively from 21.2% to 23.1% during the 6-yr period.
However, none of these data were recorded within the
3 months before or after the TdF victories. In addition, the study
results were subsequently challenged based on the calcula-
tions used to derive efficiency and the equipment used during
the investigations, claims that were refuted by the study_s
author (26). Lastly, the athlete was retrospectively stripped of
his titles, and the results of all TdF wins were annulled based
on evidence of the use of prohibited substances and methods.
As a result, the observed results from this report should be
reviewed with caution given the potential effect of performance-
enhancing substance abuse during this period of testing.
Although limited in scope, one study has described physio-
logical data pertaining to blood lactate parameters in a TdF
winner in close to peak condition (33). The tests were performed
within 2 months of the athlete_s 4th TdF victory and shortly
before a successful World Hour Record performance. During a
graded cycling ergometer step test protocol (35-W increments
every 4 min) to exhaustion, a PPO of 572 W (7.06 WIkgj1)
was recorded. The power output recorded at 4 mmolILj1 blood
lactate concentration was 505 W (6.23 WIkgj1). These
authors also demonstrated that the power associated with
4 mmolILj1 blood lactate concentration was highly pre-
dictive for the maximal effort that the athlete was able to
sustain for 1 h during the Hour Record performance.
A study of a regular top 10 TdF finisher has described
training loads and performance data collected in the field for
a period of 6 yr (37). The highest recorded power outputs for
durations of 45 and 60 min (which correspond closely to
power outputs associated with 4 mmolILj1 blood lactate)
were 5.9 and 5.7 WIkgj1, respectively. These are consid-
erably lower than the relative power values recorded for a
previous TdF winner at 4 mmolILj1 blood lactate before a
World Hour Record attempt (33).
Despite extensive research into the physiological de-
mands of professional cycling and the physiological char-
acteristics of riders, there is a limited amount of data
identifying the potentially unique characteristics of grand
tour winners. Accordingly, we conducted a physiological
assessment of a double TdF Champion, including peak oxy-
gen consumption, peak and submaximal power output, blood
lactate response, body composition, and thermoregulatory
responses, during a period when he was close to maximal
training status. These tests provide key insights into the
physiological requirements to win a race of this magnitude.
METHODS
Participant. The participant was a 30-yr-old elite male
cyclist competing in the UCI World Tour Series. At the time
of testing, he was the reigning and two-time TdF champion.
Testing was conducted 1 wk before competing in the final
Grand Tour of the 2015 road cycling season (La Vuelta
de Espan˜a).
Informed consent and ethics statement. The par-
ticipant completed written informed consent after a detailed
explanation of all data collection procedures before the
performance of any testing. Included in the written consent
was a statement detailing permission for the publication of
all collected data and the likelihood that their identity be
evident irrespective of the anonymization of resulting pub-
lished work. Approval by an independent ethics committee
was not deemed necessary for several reasons, including the
following: the participant approached the laboratory and
requested that the tests be conducted on him and was
therefore a volunteer with no recruitment process, the par-
ticipant specifically requested that the results of the tests be
published in a peer-reviewed scientific journal because of
the general and scientific interest that these results would
generate, and the data were collected as an observation on a
single day, and no intervention, experimental method, or
prospective nature was applied.
Pretesting procedures. On arrival at the laboratory,
testing procedures and schedules were verbally communi-
cated before the completion of written informed consent and
a pretest health screening questionnaire. The sequence of the
tests was as follows: body composition and bone mineral
content (BMC), submaximal aerobic profile in ambient
conditions, maximal aerobic profile in ambient conditions,
and a submaximal aerobic profile in hot and humid (HH)
conditions. All tests and procedures were conducted on the
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same day and in accordance with GSK Medical Governance
approval and GSK Human Performance Lab standard oper-
ating procedures.
Body composition and BMC. Body composition was
measured using dual-energy x-ray absorptiometry (GE Lunar
iDXA, GE Healthcare, Bucks, UK). The scan was performed
after an overnight fast (98 h), a morning urinary void, and with
all metal artifacts removed. Fasted body mass was then mea-
sured using a digital column scale (seca 704; seca Ltd.,
Hamburg, Germany). The scan was performed in accordance
with the manufacturer_s guidelines for patient positioning
and was analyzed using enCORE Software, version 14.10
(GE Healthcare). On the basis of the participant_s size
characteristics, the scan was undertaken using the ‘‘standard
thickness’’ mode. In addition to regular machine calibration,
a standard quality assurance (QA) procedure was performed
and passed before the test (laboratory coefficient of variation
for this QA procedure is 0.07%).
Aerobic profile and thermoregulatory response
protocol (ambient conditions). Aerobic profiling (pul-
monary gas exchange, heart rate, and blood lactate) was
conducted 2 h postprandial (all food consumed by the par-
ticipant was self-selected) to control for the blood glucose
response and was subdivided into two parts: submaximal
and maximal. In addition to aerobic profiling, several ther-
moregulatory responses (core temperature, skin temperature,
sweat rate, and sweat electrolyte content [sodium; Na+])
were collected throughout the test. Preexercise temperature
(-C), relative humidity (RH), and barometric pressure (mb)
were 19.5-C, 49.3% RH, and 1016.2 mb, respectively. Fan
cooling was provided for the participant throughout all cycle
testing; a floor fan was positioned on the front right of the
participant at a 45- angle and set to an air speed of 5.8 mIsj1.
An electronically braked indoor cycle trainer (CompuTraineri;
RacerMate Inc., Seattle) was used in conjunction with the
participant_s personal bicycle (Pinarello Dogma F8, Pinarello,
Treviso, Italy) to complete the test. The CompuTraineri
system was selected as it allows the participant to use their
own bicycle and does not require a set cadence to elicit a
constant power, allowing the participant to cycle at a self-
selected cadence. The crank arm length was 175 mm, and an
oval chain ring (Osymetric USA, Winston-Salem, NC) was
used. After a 10-min self-selected warm-up, the cycle trainer
rolling resistance was calibrated to reflect a tire-load gen-
erator pressure of 0.93 kg. The indoor cycle trainer software
(RacerMate One, RacerMate Inc.) was programmed to
elicit an incremental step test, starting at 250 W with in-
creases in work rate of 25 W every 4 min. An online (i.e.,
continuously measured/real time) gas analyzer (Metalyzer
3B; Cortex, Leipzig, Germany) was used throughout the
protocol to measure oxygen and carbon dioxide fractions
and volume of gas in inspired and expired air. The analyzer
was warmed up and calibrated for oxygen (17%) and car-
bon dioxide (5%) fractions and gas volume (3 L syringe) as
per manufacturer_s prescription. During the tests, the par-
ticipant breathed through a low dead space (70 mL) mouth
piece, low resistance turbine (G0.1 kPaILj1Isj1 at 16 LIsj1),
while inspired and expired gas was sampled continuously at
50 Hz. The analyzer rise time and the transit delay for O2 and
CO2 were G100 ms and 800–1200 ms, respectively, using a
dynamic calculation for each breath.
In addition to the continuous collection of expired gas,
heart rate, and thermoregulatory data, in the final 30 s of
each exercise step, blood lactate and rating of perceived
exertion (5) were assessed. The submaximal test was ter-
minated at the end of the step that produced a blood lactate
concentration of 94 mmolILj1. After completion of the
submaximal test, a 15-min rest period was provided before
commencing the maximal test. During this period, the
participant was able to consume water ad libitum and cycle
at G100 W. The indoor cycle trainer was recalibrated, and
the software was programmed to elicit an incremental
ramp test starting at 150 W, increasing at a rate equiva-
lent to 30 WIminj1. The participant was instructed to
continue cycling for as long as possible and to maintain a
cadence of 970 rpm. Expired gas and heart rate were
collected throughout the test. The test was terminated
when the participant was unable to maintain a cadence of
970 rpm.
Assessment of submaximal oxygen cost (V˙O2)
and peak oxygen uptake (V˙O2peak). To assess for V˙O2
and V˙O2peak, expired gas data were averaged across 30-s
intervals using the online gas analysis software (MetaSoft
Studio, Cortex) before downloading for subsequent as-
sessment. V˙O2 was represented as the final 30 s of expired
gas from each step in the submaximal test; V˙O2peak was
calculated as the highest 30 s average collected during the
maximal test (19). Routine QA records demonstrated a
laboratory coefficient of variation (mean) for V˙O2 data of
1.8% in the range of 2.05–3.94 LIminj1.
Gross efficiency. Gross efficiency of the participant
was assessed by calculating the amount of work completed
relative to the amount of energy expended during each of the
submaximal test stages using the following equation:
grossefficiency %ð Þ ¼ workrate Wð Þ=energycost JIsj1   100:
Work rate was converted to joules per second to quantify
energy output, and the tables of Lusk (24), in accordance
with stage RER and V˙O2 (average of last 60 s of stage
[36]), were used to identify energy cost. Energy output as a
percentage of energy cost was used to express GE. Stage
and overall mean GE values were calculated (8,9) for the
submaximal trials in ambient and HH conditions; however,
it should be noted that GE data calculated for power out-
puts above steady-state exercise may be influenced by the
V˙O2 slow component and as a result should be interpreted
with a degree of caution.
PPO. PPO was calculated from the data collected in the
maximal aerobic test. PPO was determined as the highest 30 s
average from the incremental ramp test and subsequently
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expressed relative to bodymass. A comparison of the recorded
power output data from the RacerMate software was made
with the data collected from the athlete_s personal power
meter (Stages Cycling, Kirchzarten, Germany) and the set
ramp test power on the CompuTraineri. This analysis
demonstrated that power output was within 0.7% T 2.2%
according to the power meter and within 0.7% T 0.8% of the
programmed power during the maximal test according to the
RacerMate software.
Blood lactate sampling. Capillary blood samples
were collected from the earlobe before warm-up and in the
final 30 s of each stage during the submaximal aerobic test.
Briefly, 20 KL of blood was collected into a capillary tube
before being analyzed using an automated blood lactate
analyzer (Biosen C-Line; EKF Diagnostics, Cardiff, UK).
The coefficient of variation for blood lactate measurement in
the laboratory was 0.27% in the range 2–18 mmolILj1.
Heart rate. Heart rate was collected continuously via a
wireless telemetry system (Polar T34; Polar Electro (UK)
Ltd., Warwick, UK). In the submaximal aerobic test, heart
rate data from the final 30 s of each stage were used for
further analysis, whereas in the maximal test, heart rate data
collection was incomplete because of a signal dropout mid-
way through the test.
Power and heart rate at landmarks associated
with blood lactate thresholds. Because of the lack of a
‘‘gold standard’’ measure and conjecture surrounding the use
of a single landmark to define lactate thresholds (3), several
landmarks were calculated. Blood lactate concentrations and
heart rates collected during the ambient and HH submaximal
trials were inserted into validated software (Lactate-E [29]),
which subsequently calculated the predicted power and heart
rates at the following reported landmarks: 1 mmolILj1 above
baseline, DMAX (6), modified DMAX (3), 2 mmolILj1, and
4 mmolILj1. Subsequently, the predicted power at these
landmarks was expressed relative to current and predicted
race body mass (WIkgj1).
Core temperature. Core temperature (Tc) was recorded
using a noninvasive technique. During breakfast, the par-
ticipant opened a sealed package containing a core tem-
perature sensor pill (CorTemp, Palmetto, FL) and consumed
it with water after the removal of the magnet that activates
the pill. A CorTemp data recorder (CorTemp) wirelessly
received the signal from the pill (sampling rate was 0.1 Hz)
and converted it into a digital format, displaying temperature
in real time and saving for subsequent analysis. Manufacturer
documentation reports the CorTemp sensor to be accurate
to within T0.1-C. The sensor was consumed 2 h before the
aerobic profiling session to ensure the pill was settled in
the participant_s digestive tract, minimizing the influence
of fluid consumption.
Skin temperature. Skin temperature (Ts), using a sin-
gle site measurement, was monitored using a medical grade
thermal validation system (E-Val Flex; Ellab, Hileroed,
Denmark) at a sampling rate of 60 Hz and a resolution of
0.01-C (manufacturer reported accuracy is T0.05-C). Once
the participant was in a comfortable position on the bike, a
skin thermistor (MHD Flexible Plast Foil, Ellab) was affixed
to the center of the left scapular region using surgical tape
(Micropore; 3M, Loughborough, UK), after which Ts was
recorded continuously until the end of each cycling test.
A single site measurement was selected because of wire
placement logistics and participant comfort. This positioning
also allowed the thermistor to be shielded from airflow of
the cooling fan.
Sweat rate and electrolyte content. During aerobic
profiling sessions, the participant_s sweat was collected
for analysis of electrolyte content using absorbent
patches. The patches (Tegaderm, 3M) were affixed to
four regions on the right side of participant_s body:
forearm (middorsal), chest (superior to the nipple, ~5 cm
lateral from the sternum), back (spine of the scapula and
~7 cm lateral from the vertebral column), and thigh
(midventral). Each site was cleaned and dried before the
application of patches, using distilled water, gauze, and
latex free gloves to avoid contamination of the collection
area. After testing, each patch was removed using sterile
disposable tweezers and placed in to a vial for later ex-
traction. Sweat was extracted from the patch using cen-
trifugation (Heraeus Multifuge 3S-R; Thermo Scientific,
Waltham, MA) at 3600 rpm for 10 min. Sweat electrolyte
(Na+) concentration was measured using flame photome-
try (Sherwood Scientific Model 420 Dual Channel Flame
Photometer, Cambridge, UK). Subsequently, absolute sweat
electrolyte losses were calculated by multiplying the con-
centration of each electrolyte (mmolILj1) by the volume of
fluid loss (L) during the session and time corrected to attain
electrolyte loss per hour. To determine sweat rate, changes
in pre- and postexercise body mass were measured and
corrected for fluid consumption. The participant showered
after completing the ambient aerobic profile, and before and
after the HH testing session, the same patching and analysis
process was followed.
Submaximal aerobic profile and thermoregula-
tory response (HH conditions). To determine the re-
sponses of the participant in HH conditions, which are
regularly encountered during UCI World Tour cycle racing,
the submaximal aerobic test was repeated in an environ-
mental chamber (TIS Services, Alton, UK). The test was
completed 2 h postprandial and followed the same pro-
cedures described previously. The chamber was set to pro-
vide the environmental conditions of 30.0-C, 60.0% RH,
and 1015.0 mb. As per the previous submaximal test, heart
rate, expired gas, and thermoregulatory data were continu-
ously collected, whereas blood lactate and rating of perceived
exertion were collected in the final 30 s of each exercise step.
The termination criterion for the test was also replicated.
RESULTS
Body composition and BMC. Fasted body mass was
70.0 kg, as measured using the digital column scale, and the
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participant_s body fat percentage was 9.5%. Total fat, lean
mass, and BMC were 6.7, 61.5, and 2.8 kg, respectively. (NB
Body composition values are calculated based on the body
mass estimated by the GE Lunar iDXA [71.0 kg].) Soft tissue
body composition was further analyzed in three distinct body
regions: arms, legs, and trunk. Regional fat mass was 0.9, 2.0,
and 3.0 kg and lean mass was 7.0, 20.6, and 30.7 kg for arms,
legs, and trunk, respectively.
Submaximal V˙O2, V˙O2peak, and GE. V˙O2 increased
linearly with increases in stage power across the submaximal
tests in both ambient (R2 = 0.99; [y = 0.0122x + 0.1473]) and
HH (R2 = 0.99; [y = 0.0132x – 0.2217]) conditions, with
similar absolute V˙O2 recorded for each stage. V˙O2peak was
5.91 LIminj1, which expressed relative to body mass was
84 mLIkgj1Iminj1. We were unable to determine peak heart
rate because of a signal dropout at 11 min 31 s into the test,
at which point heart rate was 154 bpm (self-reported maxi-
mum heart rate in competition was ~170 bpm). Mean GE
values were 23.0% and 23.6% for ambient (range; 22.3%–
23.3%) and HH (range; 22.7%–24.2%) conditions, respectively
(Fig. 1). Mean cadence values were 95.9 T 2.2 and 96.3 T
1.9 rpm for ambient and HH conditions, respectively.
PPO. PPO, the highest 30 s power output from the
maximal aerobic test, was determined as 525 W, equating to
7.5 WIkgj1 when expressed relative to body mass (69.9 kg
immediately pretest). Mean T SD, minimum, and maximum
cadence were 97 T 2.9, 62, and 104 rpm, respectively.
Submaximal lactate profile and associated power
and heart rate values. Absolute power output, relative
power output, and race mass relative power output at the
following blood lactate landmarks were calculated: 1 mmolILj1
above baseline, DMAX (6), modified DMAX (3), 2 mmolILj1,
and 4 mmolILj1 for both ambient and HH submaximal trials
(Table 1). In addition, associated heart rates and blood lactate
values are presented. A graphical representation of the sub-
maximal lactate profile is presented in Figure 2.
Submaximal Tc and Ts responses. Tc increased
steadily with increases in stage power across the submaximal
tests in both ambient and HH conditions (Fig. 3). Tc increased
more rapidly and to a higher peak temperature in the HH
conditions (38.6-C vs 38.2-C).
Starting Ts was 1.0-C higher in HH compared with ambi-
ent conditions (33.1-C vs 34.1-C) (Fig. 3) and was elevated
above ambient values throughout the test. Ts increased rapidly
to a peak of 35.4-C in the early stages of the HH test, whereas
in ambient conditions, Ts peaked in the final stage and at a
lower temperature (33.5-C).
Sweat analysis. Sweat rates during the submaximal
aerobic tests were 1.42 and 1.70 LIhj1 in the ambient and HH
conditions, respectively. After sweat composition analysis, the
rate of Na+ loss was calculated as 1.64 gIhj1 (50.3 mmolILj1)
in ambient and 1.92 gIhj1 (58.9 mmolILj1) in HH conditions.
DISCUSSION
To our knowledge, we present the first data from a winner
of the TdF that includes peak oxygen consumption, PPO,
FIGURE 1—Comparison of GE across submaximal aerobic profile in
ambient (19.5-C, 49.5% RH, 1016.2 mb) and HH (30-C, 60.0% RH,
1015.0 mb) conditions.
TABLE 1. Power and heart values at selected lactate landmarks.
Blood Lactate Landmark Power (W)a Relative Power (WIkgj1)b Race Weight Relative Power (WIkgj1) Heart Rate (bpm) Lactate (mmolILj1)
Baseline
Ambient N/A N/A N/A N/A 1.09
HH N/A N/A N/A N/A 0.99
1 mmolILj1 above baselinec
Ambient 382 5.4 5.7 128 2.09
HH 390 5.5 5.8 139 1.99
DMAX
Ambient 356 5.0 5.3 121 1.36
HH 357 5.2 5.5 131 1.11
Modified DMAX
Ambient 385 5.4 5.8 129 2.22
HH 392 5.5 5.9 139 2.04
Fixed blood lactate (2 mmolILj1)
Ambient 379 5.4 5.7 127 2.00
HH 390 5.5 5.8 139 2.00
Fixed blood lactate (4 mmolILj1)
Ambient 419 5.9 6.3 138 4.00
HH 430 6.1 6.4 149 4.00
aCalculated using Lactate-E software (8).
bAmbient weight = 70.8 kg; HH weight = j71.0 kg.
cValues derived using third-order polynomials (lactate vs power, lactate vs heart rate).
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submaximal power output, and blood lactate data, collected
when the athlete was close to peak physical condition. The
participant had won the TdF 22 d before the testing and was
in preparation for the final 3-wk stage race of the year,
which started 5 d after the testing date and was therefore
arguably, excluding the increase in body mass, in peak
physical condition.
An unexpected finding was the higher than anticipated
body fat percentage of 9.5%. Previous work in male U.S.
Cycling Federation athletes reported a mean body fat of
4.7% in male road cyclists (44), although these measures
were collected via an alternate method (seven site skinfolds
[16]), which has previously been reported to underestimate
fat percentage when compared with dual-energy x-ray ab-
sorptiometry (7,10). Conversely, a mean body fat of 10.2%
was reported in professional road cyclists (43); however,
these measurements were taken in preseason where the
condition of the athletes is unlikely to be optimal. Anec-
dotally, the athlete in this case study reported that in the
3 wk after the TdF (i.e., immediately before testing), they
had gained 3–4 kg of body mass. Aside from the potential
differences in mass because of changes in hydration status
and glycogen stores, a large amount of this added mass
might be represented by added body fat.
The PPO of 525 W is considerably greater than data
published for 10 internationally competitive male cyclists
(445 T 52 W) (30). However, this is lower than that recorded
for another TdF winner in peak condition (572 W) (33) and
also lower than the highest PPO recorded from a group of
professional cyclists (585 W) using a similar ramp protocol
(22). This can primarily be attributed to the large variations
in body mass and somatotype among elite cyclists (13). The
standardization of power data is therefore best expressed as
power relative to body mass. When expressed in relative
terms, the PPO of 7.5 WIkgj1 is among the highest recorded
for any professional cyclist. Relative to other TdF winners,
this value is considerably higher than previously recorded
(7.06 WIkgj1) (33). However, the comparative data were
collected using differing protocols, which can significantly
influence these results, for example, higher ramp rates
yielding higher PPO (39). It is, however, lower than the best
value recorded from a group of European professional cy-
clists (7.70 WIkgj1) who used a similar ramp protocol (22).
If calculated using the athlete_s self-reported race mass
(67 kg), the relative peak power of 7.84 WIkgj1 would
be the highest recorded to date.
The workload at 4 mmolILj1 has been well correlated
with professional cycling performance in the field in TT
stages and uphill cycling, two characteristics required to excel
at stage racing (34). Submaximal power at 4 mmolILj1
(6.1 WIkgj1) was significantly higher than that reported
for top international road cyclists who excel at TT stages
(5.7 T 0.2 WIkgj1) and uphill cycling (5.7 T 0.5 WIkgj1)
(28). However, this value is very close to that recorded for
another TdF winner when tested in peak condition
(6.2 WIkgj1) (34). Once again, if calculated using the
athlete_s self-reported race mass, the relative power at
4 mmolILj1 (6.4 WIkgj1) would be the highest value re-
ported to date. Comparisons to other studies of submaximal
workloads in relation to blood lactate concentrations are con-
founded by the multiple differing methods, lack of reporting of
the methods, and a lack of standardization with respect to the
methods used to analyze blood lactate concentrations.
FIGURE 3—Comparison of core temperature (A) and skin tempera-
ture (B) during submaximal aerobic profile in ambient (19.5-C, 49.5%
RH, 1016.2 mb) and HH conditions (30.0-C, 60.0% RH, 1015.0 mb).
FIGURE 2—Lactate and heart rate responses to submaximal step tests
in ambient and HH environmental conditions.
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Mean GE across both ambient and HH conditions (23.3%),
as well as the mean GE for the two submaximal trials at 80%
of V˙O2peak (23.2%), compared favorably to the values de-
scribed previously (22). All of the athletes tested in this report
that recorded a GE greater than 22% also recorded V˙O2peak
values less than 77mLIkgj1Iminj1 (22). The results presented
in this case study therefore demonstrate a uniquely high
V˙O2peak in combination with a high GE, two characteristics
that are required to sustain the very high submaximal power
outputs required to win the TdF (Fig. 4).
The GE in HH conditions declined as a function of work
rate in keeping with previously published data (14), whereas
in normal ambient conditions, efficiency initially increased
at low work rates and declined above work rates of 360 W.
GE at lower work rates (G350 W) was greater in HH con-
ditions than that in ambient conditions, whereas at higher
work rates, the GE was similar for both ambient and HH
conditions. The differences between the values recorded
exceeded the typical error of measurement for GE (27) by a
considerable margin. This increased efficiency at lower
work rates in HH conditions is in contrast to the study by
Hettinga et al. (15), who demonstrated that GE for a group
of well-trained cyclists in hot conditions (35.5-C, 15.5%
RH) was on average 0.9% lower than that in cool conditions
(15.6-C, 20.0% RH). Similarly, submaximal power output
values recorded at various blood lactate landmarks were
higher in HH than in ambient conditions, which may be
directly attributable to the improved GE. The mechanism
underpinning higher GE in HH conditions is difficult to as-
certain. Potentially, an efficient thermoregulatory response
allowed the maintenance of lower muscle temperatures, which
has been shown to allow higher degrees of glycolysis (4) and
subsequently may allow for more efficient energy production.
The participant expressed anecdotally that he performs
well in hot environmental conditions. The improved GE and
submaximal power outputs in HH conditions appear to
support this; however, it should be noted that because both
ambient and HH trials were performed on the same day, we
were unable to control for circadian rhythm and any asso-
ciated fluctuations in physiology (41). Despite the higher
than anticipated body fat percentage for an elite cyclist, the
athlete_s low bodymass index (19.4 kgImj2) and ectomorphic
somatotype may predispose to maintenance of performance
or reduced decrement in performance in the heat (11,18,42).
Furthermore, in line with other highly trained athletes, the
participant_s sweat rate was relatively high in both ambient
and HH conditions, suggesting an efficient thermoregulatory
response to exercise (38). Interestingly, the sweat Na+ con-
centrations in both conditions were similar and of moderate
magnitude (50–60 mmolILj1), which is also indicative of
well-developed acclimation to HH environments.
Before the tests conducted for this case study, the partic-
ipant had only undergone performance laboratory testing on
one previous occasion in 2007 (an interval of 8 yr between
tests). A longitudinal analysis of the two data sets may well
be confounded by the use of different methodologies and
protocols, and at the time of publication, we were unable to
establish the specific methods used to collect the data in
2007. However, taking into account these confounding fac-
tors, some differences are clear, providing some interesting
insight. The participant_s mass recorded in 2007 was 75.6 kg.
This is 4.8 kg greater than that recorded on the day of testing
(70.8 kg) and approximately 8 kg greater than the self-
reported race mass of the participant (67 kg). This equates to
a change in mass of 10.5%. The reduction in mass appears
to have been predominantly through the loss of body fat
mass. The recorded body fat percentage was 16.9% in 2007
in comparison with 9.5% for the more recent test; however,
differing methodologies may result in significant differ-
ences in the determination of body fat percentage (17). It is
therefore not possible to conclude definitively whether the
mass lost by the participant was predominantly fat mass,
muscle mass, or a combination of both. Such a large reduction
in mass would have an equivalent or greater performance-
enhancing effect during uphill racing provided that the
ability to produce power was not adversely effected. The
PPO of 525 W compares favorably to the PPO of 540 W
reported in 2007 when expressed relative to body mass
(7.5 vs 7.1 WIkgj1).
CONCLUSION
In conclusion, we present a broad range of physiological
variables from a two-time TdF winner. These values were
recorded at close to peak condition and therefore arguably
represent the extremes of human endurance performance
characteristics. The values for PPO, V˙O2peak, submaximal
power outputs, and GE are among the highest reported for
professional road cyclists.
Body fat was higher than previously reported for profes-
sional cyclists, which may be explained by the athlete_s self-
reported 4 kg increase in body mass since his second TdF
win. When recalculated, relative values using the reported
FIGURE 4—GE (%) at 80% of V˙O2peak (mean of ambient and HH) vs
V˙O2peak from this case study (h, recorded mass; j, self-reported race
mass) in comparison with those from a group of professional cyclists ())
modified from Lucia et al. (22).
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competition body mass, PPO, and submaximal power at
4 mmolILj1 blood lactate concentration are the highest
values published to date.
Two unique characteristics of this case report are the high
GE in relation to V˙O2peak when compared with that reported
for other professional cyclists, and the potential for strong
performance in HH conditions owing to higher GE and
lower submaximal blood lactate versus those presented in
ambient conditions. This may in part be explained by effi-
cient thermoregulatory processes as well as by the higher
GE recorded during the first half of the exercise bout
conducted in HH conditions. The characteristics of a high
V˙O2peak and high GE are critical to sustaining high power
outputs. Such traits are a requirement to excel in TT and
uphill stages finishes, two areas where time is usually gained
over other stage race competitors. The TdF takes place in
midsummer and usually experiences high temperatures and
humidity on many stages. The ability to maintain perfor-
mance in the heat may therefore be an important contribut-
ing characteristic to performance in this race and is reflected
in the athlete_s TdF performances to date.
In summary, these data provide a unique insight into the
characteristics required to succeed at the TdF, the sport of
cycling_s leading event.
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